OpenAI worked with Retro Biosciences to develop GPT-4b micro, an AI model that it says can engineer proteins capable of turning regular cells into stem cells
When you think of AI's contributions to science, you probably think of AlphaFold, the Google DeepMind protein-folding program that earned its creator a Nobel Prize last year.
MIT Technology ReviewAntonio Regalado
Context & Ripple Effects
AlphaFold established protein-structure prediction as a major scientific AI use case, following its breakthrough in predicting protein structures. This collaboration moves the focus from predicting biological structures toward using models in a targeted cell-engineering workflow.
It also anticipates OpenAI’s later life-sciences research model preview, indicating a progression from a partner-specific biological model to a broader life-sciences product direction.
First-order effects
Retro Biosciences gains access to a jointly developed model aimed at protein engineering for cell reprogramming, while OpenAI adds a concrete biology application to its model portfolio.
The work tests whether a language-model-based system can contribute to protein design rather than only interpret biological information.
Second-order effects
Protein-AI competitors will face greater pressure to show that their systems can support experimentally relevant design tasks, not just structure prediction.
Biotech partners may increasingly evaluate AI vendors on their ability to adapt models to specialized research workflows and proprietary data.
Third-order effects
If such models prove useful in experiments, scientific AI could shift from standalone prediction tools toward workflow-native systems that connect model outputs to biological engineering decisions.
The key constraint will remain validation: progress in model capability will matter commercially only when it translates into reproducible laboratory outcomes.
The trend: This is one data point in the shift from general-purpose AI models toward specialized, partner-led systems for scientific discovery and engineering.
OpenAI announces a ... “bespoke demonstration” of a new model called GPT-4b micro - an AI built to help manufacture stem cells. www.technologyreview.com/2025/01/17/ 1...
Google DeepMind won a Nobel Prize for protein prediction. — Now OpenAI says it's getting into the game as well, with model trained on protein sequences that' being used in longevity research. — www.technologyreview.com/2025/01/17/ 1...
THIS IS HUGE 🚨 openAI has created an AI model for longevity science according to the article, openAI new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their function. according to openAI, researchers used the model's [image…
Our Applied AI team at @RetroBio_ + some @OpenAI homies working together for a few month have created GPT4b-micro, a sequence-based model for, among other things, protein design!
„OpenAI's new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their function. According to OpenAI, researchers used the model's suggestions to change two of the Yamanaka factors to be more than 50 times as effective—at least …
Every step toward the impossible is a triumph of the human will. Resolving aging is not just a breakthrough, it is the first act of fully embracing life by eradicating the shadows of death. That's all.
This is super cool! I might need to revise my prediction for reversing aging from 20 years to an earlier date soon! Also, I really need this GPT-4b now 😭🙏 “OpenAI's new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their [i…